http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0447014-B1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_da54f7ebbd2d9d8a82f92aca4d1b4e48
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J43-003
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J41-0083
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J21-006
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J21-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J41-00
filingDate 1991-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1995-11-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0013552a1230a8354222007a67a7f65a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3ade06dc4c26eb98588256f6dfb6b91b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_da5387ada97b0c7d187c20f4048bf98a
publicationDate 1995-11-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-0447014-B1
titleOfInvention Process for the preparation of intermediates used in the synthesis of progesterone antagonists (synthesis of onapristone)
abstract A process for the preparation of intermediates of the general formula III <IMAGE> in which Z, R<1> and R<2> have the meaning indicated in the description, is described and entails a compound of the general formula II <IMAGE> in which R<2> and Z have the meaning indicated in formula III, being reacted with a compound of the formula <IMAGE> (Hal = halogen) with the addition of a Cu(I) salt. These intermediates are suitable for the preparation of antigestagens (especially Onapristone, EP-A 0 129 499).
priorityDate 1990-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10904793
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID81531
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399859
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11465
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11723
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226441856
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127871487
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128876256
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399016
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54013364
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13340398
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129761382
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5311505
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128876255
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13371204
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5994
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128434167
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID234619489
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID234619264
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID234619860
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394385

Total number of triples: 39.